Where can the workbooks be found?
All workbooks can be found on the resources page.
Do physicians and nurse practitioners need to complete the education and training pathway to prescribe buprenorphine/naloxone?
Physicians and nurse practitioners are not required to complete the education and training pathway in order to prescribe buprenorphine/naloxone; however, they are strongly encouraged to take the POATSP Online Course.
Why do nurse practitioners no longer need to complete the education and training pathway to prescribe buprenorphine/naloxone?
As of April 22, 2022, nurse practitioners are no longer required to complete the education and training pathway to prescribe buprenorphine/naloxone. Learning opportunities will continue to be offered for nurse practitioners for prescribing buprenorphine/naloxone, including online education and in-person preceptorships; however, this is optional.
The BCCSU conducted a review of the nurse practitioner education and training pathway for buprenorphine/naloxone prescribing and consulted with key stakeholders. This confirmed that removing this education and training pathway requirement may better support the expansion of buprenorphine/naloxone treatment, particularly in rural and remote communities.
Nurse practitioners are strongly encouraged to take the POATSP Online Course to learn the latest evidence-based guidance for prescribing buprenorphine/naloxone and for more information about induction protocols.
Do prescribers need to obtain an exemption under subsection 56(1) of the Controlled Drugs and Substances Act (CDSA) to prescribe methadone?
No. As of May 19, 2018, Health Canada removed the requirement for clinicians to obtain an exemption under section 56(1) of the CDSA to prescribe and administer methadone.
As per the Prescribing Methadone Practice Standard by the College of Physicians and Surgeons of BC, registrants who do not currently have a section 56(1) exemption, or have not prescribed in more than three years must obtain the relevant education and training through the BCCSU.
Is a renewal for prescribing opioid agonist treatment (OAT) medications required?
No renewal is required. Once prescribers have obtained a Proof of Completion letter does not expire (excluding direct follow up or disciplinary action from the Colleges).
|Medication||Initiation||Continuations (including missed doses)||Titrations||Restarts (up to 30 consecutive days since last dose)|
|Slow-release oral morphine||Cross||Tick||Tick||Tick|
- First Nations Health Authority: [email protected]
- Fraser Health Authority: [email protected]
- Interior Health Authority: [email protected]
- Northern Health Authority: [email protected]
- Island Health Authority: [email protected]
- Vancouver Coastal Health Authority: [email protected]
- Provincial Health Services Authority: [email protected]